SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-17-000145
Filing Date
2017-11-17
Accepted
2017-11-17 14:17:44
Documents
56
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ebio-093017x10q.htm 10-Q 725178
2 EXHIBIT 31.1 ebio-093017x311.htm EX-31.1 12086
3 EXHIBIT 31.2 ebio-093017x312.htm EX-31.2 11938
4 EXHIBIT 32.1 ebio-093017x321.htm EX-32.1 7016
  Complete submission text file 0001485003-17-000145.txt   4026112

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ebio-20170930.xml EX-101.INS 783793
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebio-20170930.xsd EX-101.SCH 30002
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebio-20170930_cal.xml EX-101.CAL 72291
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebio-20170930_def.xml EX-101.DEF 141934
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebio-20170930_lab.xml EX-101.LAB 455859
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebio-20170930_pre.xml EX-101.PRE 268105
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 171210558
SIC: 2834 Pharmaceutical Preparations